Cambio - Excellence in Molecular Biology

Oligo Synthesis

Oligo Synthesis : CEPs

Prices quoted are for single packs only. For multiples of the same product please request a quote. Some of Glen's products are hazardous and may be subject to additional shipping charges. Full product information is available on Glen Research's website.

AP-dC-CE Phosphoramidite

AP-dC-CE Phosphoramidite

Glen Research

Catalogue No.DescriptionPack SizePriceQty
10-1097-02AP-dC-CE Phosphoramidite 0.25g £1,173.00 Quantity Add to Order
10-1097-90AP-dC-CE Phosphoramidite 100µmoles £464.00 Quantity Add to Order
10-1097-95AP-dC-CE Phosphoramidite 50µmoles £245.00 Quantity Add to Order

Description

AP-dC-CE Phosphoramidite

Structure

Catalog Number: 10-1097-xx

Description: AP-dC-CE Phosphoramidite

1-[5'-O-(4,4'-Dimethoxytrityl)-?-D-2'-deoxyribofuranosyl]-9-
(2-trifluoroacetamidoethoxy)-1,3-diaza-2-oxophenoxazine,
3'-[(2-cyanoethyl)-(N,N-diisopropyl)]phosphoramidite
Formula: C49H54F3N6O10P M.W.: 974.97 F.W.: 438.33
Diluent: Anhydrous Acetonitrile
Coupling: No changes needed from standard method recommended by synthesizer manufacturer.
Deprotection: AMA (Ammonium hydroxide/40% Methylamine 1:1 v/v) for 10 minutes at 65 °C is recommended. Note to prevent any modification of dC by Methylamine, use Ac-dC (10-1015-xx) during synthesis.
Storage: Refrigerated storage, maximum of 2-8°C, dry
Stability in Solution: 24 hours

Please Note: This product is covered by patents or patents pending owned by Isis Pharmaceuticals, Inc. ("Isis"). Purchase of this product includes a limited license to use this product solely for internal research. This license specifically excludes (and you have no right to use this product for): (a) therapeutic or diagnostic applications (including products or services that incorporate this product), (b) any in vivo toxicity/safety study in support of an investigational new drug application (or foreign counterpart), (c) resale (including sale of any products or services that incorporate this product) or (d) gene functionalization activities (including products or services that incorporate data derived from gene functionalization activities) if such activities have commercial application, any and all of which require a separate license from Isis. Neither this product nor any product created through its use may be used in human clinical trials.

C-5 propyne derivatives and G-Clamp

Substitution of C-5 propynyl-dC (pdC) for dC and C-5 propynyl-dU (pdU) for dT are effective strategies to enhance base pairing. Using these base substitutions, duplex stability and melting temperatures are raised by the following amounts: C-5 propynyl-C 2.8° per substitution; C-5 propynyl-U 1.7° per substitution. AP-dC (G-clamp) substitutes for dC and is another very important modified nucleoside that enhances hybridization by 7.5° per substitution. The ability of these modified bases to enhance binding while maintaining specificity has proven useful in antisense research and in the synthesis of high affinity probes. AP-dC is also a fluorescent nucleoside and should find uses in DNA structural research.

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

Protocols

MSDS

Glen Report 18.1: Fluorous Affinity Purification of Oligonucleotides
Glen Report 19.2: AP-dC is compatible with PCR and is Highly Fluorescent

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

Notes

C-5 Propyne and AP-dC Phosphoramidites

This product is covered by patents or patents pending owned by Isis Pharmaceuticals, Inc. (Isis).  Purchase of this product includes a limited licence to use this product solely for internal research.  This licence specifically excludes (an you have no right to use this product for): (a) therapeutic or diagnostic applications (including products or services that incorporate this product), (b) any in vivo toxicity/safety study in support of an investigational new drug application (or foreigh counterpart), (c) resale (including sale of any products or services that incorporate this product), or (d) gene functionalisation activities (including products or services that incorporate data derived from gene functionalisation activities) if such activities have commercial application, any and all of which require a separate licence from Isis.  Neither this product nor any product created through its use may be used in human clinical trials.

A simple agreement must be signed before end-users and custom oligo services amy purchase these products for use as defined above.

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

Applications & Benefits

EXTINCTION DATA

Item Nucleoside λMax-1 Emax-1 λMax-2 Emax-2 E260


(nm) (ml/µmole) nm (ml/µmole) (ml/µmole)
10-1097
362nm 10.5

10.9

DILUTION/COUPLING DATA

The table below shows pack size data and, for solutions, dilutions and approximate couplings based on normal priming procedures. Please link for more detailed usage information with the various synthesizers.

ABI 392/394
Cat.No. Pack
Size		 Grams/
Pack		 0.1M Dil.
(mL)		 LV40 LV200 40nm 0.2µm 1µm 10µm
Approximate Number of Additions
10-1097-02 0.25grams .25grams 2.56 72 43.2 27 19.64 14.4 3.6
10-1097-90 100µmoles .097grams 1 20 12 7.5 5.45 4 1
10-1097-95 50µmoles .049grams .5 3.33 2 1.25 .91 .67 .17
Expedite
Cat.No. Pack
Size		 Grams/
Pack		 Dilution
(mL)		 Molarity 50nm 0.2µm 1µm 15µm
Approximate Number of Additions
10-1097-02 0.25grams .25grams 3.83 .07 70.2 43.88 31.91 4.39
10-1097-90 100µmoles .097grams 1.5 .07 23.6 14.75 10.73 1.48
10-1097-95 50µmoles .049grams .75 .07 8.6 5.38 3.91 .54
Beckman
Cat.No. Pack
Size		 Grams/
Pack		 Dilution
(mL)		 Molarity 30nm 200nm 1000nm

Approximate Number of Additions
10-1097-02 0.25grams .25grams 3.83 .07 71.8 44.88 32.64

10-1097-90 100µmoles .097grams 1.5 .07 25.2 15.75 11.45

10-1097-95 50µmoles .049grams .75 .07 10.2 6.38 4.64

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200

Related products

If you cannot find the answer to your problem then please contact us or telephone +44 (0)1954 210 200